Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Login
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
As of June 2026 70.60% is owned by Indian Promoters and 29.40% by Public. Top two Promoters holding highest number of shares of ANG Lifesciences Ind ...more...
Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations 2015 as amended ( Listing Regulations ) please find attached herewith the A...more...
Notice of 20th AGMmore...
Intimation of Book Closuremore...
Intimation of 20th Annual General Meetingmore...
This is to inform you pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirement...more...
Financial Results 30.06.2026.more...
Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (L...more...
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to conside...more...
Reg 74(5) Certificatemore...
The company reported standalone net profit during the quarter stood at Rs 1.10 crore compared to net loss of Rs 1.94 crore in the previous year quart...more...
Audited Results 31.03.2026more...
Audited Financial Results for the quarter and year ended 31st March 2026more...
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia t...more...
As of March 2026 70.60% is owned by Indian Promoters and 29.40% by Public. Top two Promoters holding highest number of shares of ANG Lifesciences Ind...more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company ANG Life...more...
Certificate under Reg 74(5) of SEBI (DP) Regulations 2018more...
This is with reference to the email communication received from BSE Limited on April 09 2026 seeking clarification for a significant movemen...more...
The Exchange has sought clarification from ANG Lifesciences India Ltd on April 9 2026 with reference to significant movement in price in order to ens...more...
BOARD MEETINGS Company Name : LCC Projects Date : 05-10-2026
Latest Videos